Robert Schrepfer

2019

In 2019, Robert Schrepfer earned a total compensation of $2.2M as Senior Vice President, New Business Development and Specialty Sales at ANI Pharmaceuticals, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$252,120
Option Awards$610,092
Salary$456,877
Stock Awards$826,622
Other$15,264
Total$2,160,975

Schrepfer received $826.6K in stock awards, accounting for 38% of the total pay in 2019.

Schrepfer also received $252.1K in non-equity incentive plan, $610.1K in option awards, $456.9K in salary and $15.3K in other compensation.

Rankings

In 2019, Robert Schrepfer's compensation ranked 5,526th out of 13,971 executives tracked by ExecPay. In other words, Schrepfer earned more than 60.4% of executives.

ClassificationRankingPercentile
All
5,526
out of 13,971
60th
Division
Manufacturing
2,064
out of 5,701
64th
Major group
Chemicals And Allied Products
734
out of 2,200
67th
Industry group
Drugs
617
out of 1,886
67th
Industry
Pharmaceutical Preparations
454
out of 1,398
68th

Pay ratio

Robert Schrepfer's Pay$2,160,975
Median Employee's Pay$46,642
Pay Ratio

46

to 1

In 2019, the annual total compensation of Robert Schrepfer was $2,160,975.

The annual total compensation of the median employee at ANI Pharmaceuticals was $46,642.

The ratio of Robert Schrepfer's pay to the pay of median employee was therefore 46 to one.

Source: SEC filing on April 23, 2020.

Schrepfer's colleagues

We found three more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2019.

2019

Arthur Przybyl

ANI Pharmaceuticals

Chief Executive Officer

2019

Stephen Carey

ANI Pharmaceuticals

Chief Financial Officer

2019

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like